251 related articles for article (PubMed ID: 21613804)
1. Enhanced expression of podoplanin in oral carcinomas in situ and squamous cell carcinomas.
Funayama A; Cheng J; Maruyama S; Yamazaki M; Kobayashi T; Syafriadi M; Kundu S; Shingaki S; Saito C; Saku T
Pathobiology; 2011; 78(3):171-80. PubMed ID: 21613804
[TBL] [Abstract][Full Text] [Related]
2. Differential immunohistochemical expression profiles of perlecan-binding growth factors in epithelial dysplasia, carcinoma in situ, and squamous cell carcinoma of the oral mucosa.
Hasegawa M; Cheng J; Maruyama S; Yamazaki M; Abé T; Babkair H; Saito C; Saku T
Pathol Res Pract; 2016 May; 212(5):426-36. PubMed ID: 26965914
[TBL] [Abstract][Full Text] [Related]
3. p73 expression for human buccal epithelial dysplasia and squamous cell carcinoma: does it correlate with nodal status of carcinoma and is there a relationship with malignant change of epithelial dysplasia?
Chen YK; Hsue SS; Lin LM
Head Neck; 2004 Nov; 26(11):945-52. PubMed ID: 15390192
[TBL] [Abstract][Full Text] [Related]
4. p53 expression above the basal cell layer in oral mucosa is an early event of malignant transformation and has predictive value for developing oral squamous cell carcinoma.
Cruz IB; Snijders PJ; Meijer CJ; Braakhuis BJ; Snow GB; Walboomers JM; van der Waal I
J Pathol; 1998 Apr; 184(4):360-8. PubMed ID: 9664901
[TBL] [Abstract][Full Text] [Related]
5. [Changes of simple epithelial cytokeratin during oral carcinogenesis].
Nie M; Li B; Zeng G; He Z; Chen Q; Zhou M; Luo G; Zeng X
Hua Xi Kou Qiang Yi Xue Za Zhi; 1999 Aug; 17(3):208-9, 220. PubMed ID: 12539284
[TBL] [Abstract][Full Text] [Related]
6. Podoplanin: a novel marker for oral cancer risk in patients with oral premalignancy.
Kawaguchi H; El-Naggar AK; Papadimitrakopoulou V; Ren H; Fan YH; Feng L; Lee JJ; Kim E; Hong WK; Lippman SM; Mao L
J Clin Oncol; 2008 Jan; 26(3):354-60. PubMed ID: 18202409
[TBL] [Abstract][Full Text] [Related]
7. [Bax protein expression in the carcinogenesis of human oral mucosa].
Zeng X; Chen Q; Li B; Tan N
Hua Xi Kou Qiang Yi Xue Za Zhi; 2000 Apr; 18(2):88-90. PubMed ID: 12539337
[TBL] [Abstract][Full Text] [Related]
8. [The expression of hTERT and p53 protein in pre-malignant and malignant lesions of human oral mucosa].
Wu GY; Zhu L; Feng ZQ; Peng T; Qi B
Shanghai Kou Qiang Yi Xue; 2005 Feb; 14(1):51-4. PubMed ID: 15747015
[TBL] [Abstract][Full Text] [Related]
9. Expression of vascular endothelial growth factor (VEGF) in normal oral mucosa, oral dysplasia and oral squamous cell carcinoma.
Johnstone S; Logan RM
Int J Oral Maxillofac Surg; 2007 Mar; 36(3):263-6. PubMed ID: 17141472
[TBL] [Abstract][Full Text] [Related]
10. Podoplanin expression in tumor-free resection margins of oral squamous cell carcinomas: an immunohistochemical and fractal analysis study.
Margaritescu C; Raica M; Pirici D; Simionescu C; Mogoanta L; Stinga AC; Stinga AS; Ribatti D
Histol Histopathol; 2010 Jun; 25(6):701-11. PubMed ID: 20376776
[TBL] [Abstract][Full Text] [Related]
11. Matrix metalloproteinase 7 and perlecan in oral epithelial dysplasia and carcinoma in situ: an aid for histopathologic recognition of their cell proliferation centers.
Tilakaratne WM; Kobayashi T; Ida-Yonemochi H; Swelam W; Yamazaki M; Mikami T; Alvarado CG; Shahidul AM; Maruyama S; Cheng J; Saku T
J Oral Pathol Med; 2009 Apr; 38(4):348-55. PubMed ID: 19239574
[TBL] [Abstract][Full Text] [Related]
12. Differential expression of perlecan receptors, α-dystroglycan and integrin β1, before and after invasion of oral squamous cell carcinoma.
Ahsan MS; Yamazaki M; Maruyama S; Kobayashi T; Ida-Yonemochi H; Hasegawa M; Henry Ademola A; Cheng J; Saku T
J Oral Pathol Med; 2011 Aug; 40(7):552-9. PubMed ID: 21198869
[TBL] [Abstract][Full Text] [Related]
13. [P53 expression and clinical significance in oral squamous cell carcinoma].
Long Y; Ling D; Yue W
Hua Xi Kou Qiang Yi Xue Za Zhi; 1997 May; 15(2):115-6, 122. PubMed ID: 11480024
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical study of p53 and angiogenesis in benign and preneoplastic oral lesions and oral squamous cell carcinoma.
Abbas NF; Labib El-Sharkawy S; Abbas EA; Abdel Monem El-Shaer M
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Mar; 103(3):385-90. PubMed ID: 17321451
[TBL] [Abstract][Full Text] [Related]
15. Emergence of keratin 17 vs. loss of keratin 13: their reciprocal immunohistochemical profiles in oral carcinoma in situ.
Mikami T; Cheng J; Maruyama S; Kobayashi T; Funayama A; Yamazaki M; Adeola HA; Wu L; Shingaki S; Saito C; Saku T
Oral Oncol; 2011 Jun; 47(6):497-503. PubMed ID: 21489858
[TBL] [Abstract][Full Text] [Related]
16. Ki-67 Prognostic Value in Different Histological Grades of Oral Epithelial Dysplasia and Oral Squamous Cell Carcinoma.
Takkem A; Barakat C; Zakaraia S; Zaid K; Najmeh J; Ayoub M; Seirawan MY
Asian Pac J Cancer Prev; 2018 Nov; 19(11):3279-3286. PubMed ID: 30486632
[TBL] [Abstract][Full Text] [Related]
17. Patterns of CDKN2A gene loss in sequential oral epithelial dysplasias and carcinomas.
Shahnavaz SA; Bradley G; Regezi JA; Thakker N; Gao L; Hogg D; Jordan RC
Cancer Res; 2001 Mar; 61(6):2371-5. PubMed ID: 11289098
[TBL] [Abstract][Full Text] [Related]
18. Laminin-5 gamma 2: a marker to identify oral mucosal lesions at risk for tumor development?
Nordemar S; Högmo A; Lindholm J; Auer G; Munck-Wikland E
Anticancer Res; 2003; 23(6D):4985-9. PubMed ID: 14981956
[TBL] [Abstract][Full Text] [Related]
19. Histopathological varieties of oral carcinoma in situ: Diagnosis aided by immunohistochemistry dealing with the second basal cell layer as the proliferating center of oral mucosal epithelia.
Kobayashi T; Maruyama S; Cheng J; Ida-Yonemochi H; Yagi M; Takagi R; Saku T
Pathol Int; 2010 Mar; 60(3):156-66. PubMed ID: 20403041
[TBL] [Abstract][Full Text] [Related]
20. Fhit protein expression in oral epithelium: immunohistochemical evaluation of three antisera.
van Heerden WF; Swart TJ; van Heerden MB; Pekarsky Y; Sutherland R; Huebner K
Anticancer Res; 2001; 21(4A):2419-23. PubMed ID: 11724301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
